BlackRock Inc. - ADICET BIO INC ownership

ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 82 filers reported holding ADICET BIO INC in Q4 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ADICET BIO INC
ValueSharesWeighting
Q3 2023$3,109,184
-46.4%
2,269,478
-5.0%
0.00%
Q2 2023$5,802,140
-60.3%
2,387,712
-5.9%
0.00%
Q1 2023$14,611,981
-35.8%
2,536,802
-0.3%
0.00%
-100.0%
Q4 2022$22,757,825
-24.1%
2,545,618
+20.7%
0.00%0.0%
Q3 2022$30,003,000
+11.1%
2,109,787
+14.1%
0.00%0.0%
Q2 2022$26,997,000
-16.5%
1,849,082
+14.3%
0.00%0.0%
Q1 2022$32,314,000
+27.2%
1,618,107
+11.4%
0.00%0.0%
Q4 2021$25,403,000
+159.5%
1,452,452
+16.3%
0.00%
Q3 2021$9,788,000
-23.0%
1,248,519
+1.1%
0.00%
Q2 2021$12,711,000
+98.5%
1,235,313
+152.3%
0.00%
Q1 2021$6,404,000
+66.1%
489,628
+78.4%
0.00%
Q4 2020$3,856,000
+141.9%
274,462
+104.7%
0.00%
Q3 2020$1,594,000134,0600.00%
Other shareholders
ADICET BIO INC shareholders Q4 2021
NameSharesValueWeighting ↓
Abingworth LLP 2,115,385$30,017,00010.26%
Foresite Capital Management V, LLC 680,000$9,670,0007.44%
Foresite Capital Opportunity Management V, LLC 170,000$2,417,0007.26%
DAFNA Capital Management LLC 935,766$13,307,0003.58%
COWEN AND COMPANY, LLC 2,443,246$34,743,0003.32%
JOHNSON & JOHNSON 728,944$10,366,0003.05%
Decheng Capital Management III (Cayman), LLC 580,000$8,248,0002.99%
Ally Bridge Group (NY) LLC 244,400$3,475,0002.29%
Orbimed Advisors 7,447,140$105,898,0001.97%
Cormorant Asset Management, LP 1,400,000$19,908,0001.39%
View complete list of ADICET BIO INC shareholders